Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00313_DB00949_nanopub.RAuDLtsqN7ZjvMY0WNU7MABawO8oBX99oa5DpTZDEelBk#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00313_DB00949 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00313_DB00949 label "DDI between Valproic Acid and Felbamate - Felbamate, a CYP2C19 inhibitor, may decrease the metabolism of Valproic acid, a CYP2C19 substrate. Consider alternate therapy or monitor for changes in Valproic acid therapeutic and adverse effects if Felbamate is initiated, discontinued or dose changed. [drugbank_resource:DB00313_DB00949]" assertion.
- drugbank_resource:DB00313_DB00949 identifier "drugbank_resource:DB00313_DB00949" assertion.
- drugbank_resource:DB00313_DB00949 title "DDI between Valproic Acid and Felbamate - Felbamate, a CYP2C19 inhibitor, may decrease the metabolism of Valproic acid, a CYP2C19 substrate. Consider alternate therapy or monitor for changes in Valproic acid therapeutic and adverse effects if Felbamate is initiated, discontinued or dose changed." assertion.
- drugbank:DB00949 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00313_DB00949 assertion.
- drugbank:DB00313 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00313_DB00949 assertion.